Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ming Teng

Showing results (191-200 of 249) with videos related to

Pageof 25
Sort By:
Progress in Neurobiology|March 8, 2025
NPTX2 transfection improves synaptic E/I balance and performance in learning impaired aged ratsDaniel Severin, Ming Teng Koh, Cristian Moreno, et al.
Cancer Letters|December 16, 2014
Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancerYu-Hsuan Chen, Ming-Feng Wei, Chun-Wei Wang, et al.
International Journal of Biological Macromolecules|March 19, 2025
Inhibition of aging-induced DNA hypermethylation by si-Dnmt3a/3b in pre-implantation embryos improves aberrant social behavior in offspringYing-Dong Liu, Xiao-Ming Teng, Dan-Dan Bai, et al.
Pharmacology|January 23, 2002
Effect of hexasulfobutylated C(60) on the isolated aortic ring of guinea pigShiang Suo Huang, Tadahiko Mashino, Masataka Mochizuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 5, 2004
YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cellsShih-Wei Wang, Shiow-Lin Pan, Jih-Hwa Guh, et al.
Clinical Epigenetics|May 31, 2019
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras statusMin-Wu Chao, Li-Hsun Chang, Huang-Ju Tu, et al.
Thrombosis and Haemostasis|May 12, 2005
A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse modelsShiow-Lin Pan, Jih-Hwa Guh, Chieh-Yu Peng, et al.
Molecular Cancer Therapeutics|February 19, 2008
CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivoShih-Wei Wang, Shiow-Lin Pan, Yu-Chun Huang, et al.
Urologic Oncology|December 2, 2006
E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patientsHe-Cheng Li, Jeffrey M Albert, Eric T Shinohara, et al.
European Journal of Pharmacology|November 6, 2012
Denbinobin induces human glioblastoma multiforme cell apoptosis through the IKKα-Akt-FKHR signaling cascadeHsing-Yu Weng, Ming-Jen Hsu, Chien-Chih Chen, et al.
Pageof 25

Showing results (191-200 of 249) with videos related to

Sort By:
Pageof 25
Progress in Neurobiology|March 8, 2025
NPTX2 transfection improves synaptic E/I balance and performance in learning impaired aged ratsDaniel Severin, Ming Teng Koh, Cristian Moreno, et al.
Cancer Letters|December 16, 2014
Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor is an effective radiosensitizer for colorectal cancerYu-Hsuan Chen, Ming-Feng Wei, Chun-Wei Wang, et al.
International Journal of Biological Macromolecules|March 19, 2025
Inhibition of aging-induced DNA hypermethylation by si-Dnmt3a/3b in pre-implantation embryos improves aberrant social behavior in offspringYing-Dong Liu, Xiao-Ming Teng, Dan-Dan Bai, et al.
Pharmacology|January 23, 2002
Effect of hexasulfobutylated C(60) on the isolated aortic ring of guinea pigShiang Suo Huang, Tadahiko Mashino, Masataka Mochizuki, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 5, 2004
YC-1 [3-(5'-Hydroxymethyl-2'-furyl)-1-benzyl Indazole] exhibits a novel antiproliferative effect and arrests the cell cycle in G0-G1 in human hepatocellular carcinoma cellsShih-Wei Wang, Shiow-Lin Pan, Jih-Hwa Guh, et al.
Clinical Epigenetics|May 31, 2019
Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras statusMin-Wu Chao, Li-Hsun Chang, Huang-Ju Tu, et al.
Thrombosis and Haemostasis|May 12, 2005
A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse modelsShiow-Lin Pan, Jih-Hwa Guh, Chieh-Yu Peng, et al.
Molecular Cancer Therapeutics|February 19, 2008
CHM-1, a novel synthetic quinolone with potent and selective antimitotic antitumor activity against human hepatocellular carcinoma in vitro and in vivoShih-Wei Wang, Shiow-Lin Pan, Yu-Chun Huang, et al.
Urologic Oncology|December 2, 2006
E-cadherin promoter polymorphisms are not associated with the aggressiveness of prostate cancer in Caucasian patientsHe-Cheng Li, Jeffrey M Albert, Eric T Shinohara, et al.
European Journal of Pharmacology|November 6, 2012
Denbinobin induces human glioblastoma multiforme cell apoptosis through the IKKα-Akt-FKHR signaling cascadeHsing-Yu Weng, Ming-Jen Hsu, Chien-Chih Chen, et al.
Pageof 25